Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults

Vaccine

Volumn 20, Issue 7-8, 2002, Pages 1099-1105

  Treanor, John ^a   Keitel, Wendy ^b   Belshe, Robert ^c   Campbell, James ^d   Schiff, Gilbert ^e   Zangwill, Ken ^f   Wolff, Mark ^g   Klimov, Alexander ^h   Levandowski, Roland ⁱ   Lambert, Linda ^j  

^a UNIVERSITY OF ROCHESTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g EMMES CORPORATION   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

Dose response; Healthy adults; Influenza vaccine

Indexed keywords

HEMAGGLUTININ; INACTIVATED VACCINE; INFLUENZA VACCINE;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG SCREENING; GEOMETRY; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VIRUS STRAIN;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA VACCINES; MIDDLE AGED; PROSPECTIVE STUDIES; VACCINES, INACTIVATED;

EID: 0037081382     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00440-6     Document Type: Article

References (15)

1. Prevention and control of influenza: Recommendations of the advisory committee on immunization practices (ACIP)
2. Standardization of inactivated influenza vaccine
3. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines-1978
4. Serologic respones and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines
5. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children - A multicentered evaluation of dosage and toxicity
6. Summary of clinical trials of inactivated influenza vaccine-1978
7. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus
8. Influenza viruses
9. Antibody response after influenza immunization with various vaccine doses: A double-blind, placebo-controlled, multicentre, dose-response study in elderly nursing home residents and young volunteers
10. Influenza vaccines: The effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period: A review of the literature
11. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine
12. Trials of influenza A/New Jersey/76 virus vaccine in normal children: An overview of age-related antigenicity and reactogenicity
13. Vaccines against H5N1 influenza
14. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
15. High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults